Gynecology

Combined radiotherapy and chemotherapy in gynecologic oncology

L. W. Brady, Arnold Markoe, T. DeEulis, G. C. Lewis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In 1986, 930,000 new cases of invasive cancer were anticipated to be diagnosed in the United States. During the same time period, the following numbers of gynecologic cases were to be diagnosed: 1. 45,000 cases of carcinoma in situ of the cervix. 2. 14,000 new cases of invasive carcinoma of the cervix. 3. 36,000 new cases of cancers of the corpus-endometrium. 4. 19,000 new cases of carcinoma of the ovary. 5. 4,400 new cases of other and unspecified genital tract. This represents a total of 73,400 cases of invasive gynecologic cancer and 45,000 cases of in-situ carcinoma of the uterine cervix to be seen in 1986, constituting 15% of all cancers and about 9% of all cancers in women. The desired principle of multidiscipline management for gynecologic cancer is now well established. The best results in treatment may be anticipated when the treatment is carried out by physicians well acquainted with pelvic anatomy, the characteristics of the malignant disease, and the modalities to be used, whether surgery, radiation therapy, or chemotherapy. However, radiation therapy remains the most generally applicable method for control of gynecologic cancer. At present, these malignant tumors are being discovered earlier and emphasis on the importance of surgery in the management of the early disease is increasing. As an example, more than 75% of all invasive cancers of the cervix are now Stage I and II. In dealing with the wide variety of gynecologic cancers, extreme care must be exercised to choose the appropriate treatment program for each problem since undertreatment or overtreatment are equally undesirable. Each treatment technique may have severe or fatal sequelae if inappropriately used.

Original languageEnglish
JournalInternational Journal of Radiation Oncology Biology Physics
Volume14
Issue numberSUPPL. 1
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

gynecology
chemotherapy
Gynecology
radiation therapy
Radiotherapy
cancer
Drug Therapy
Neoplasms
Cervix Uteri
Carcinoma in Situ
Carcinoma
surgery
Therapeutics
Endometrial Neoplasms
Disease Management
Uterine Cervical Neoplasms
Ovary
Anatomy
ovaries
physicians

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Gynecology : Combined radiotherapy and chemotherapy in gynecologic oncology. / Brady, L. W.; Markoe, Arnold; DeEulis, T.; Lewis, G. C.

In: International Journal of Radiation Oncology Biology Physics, Vol. 14, No. SUPPL. 1, 01.01.1988.

Research output: Contribution to journalArticle

@article{e0d589376ba94395a5f3bdc85f2aa9dc,
title = "Gynecology: Combined radiotherapy and chemotherapy in gynecologic oncology",
abstract = "In 1986, 930,000 new cases of invasive cancer were anticipated to be diagnosed in the United States. During the same time period, the following numbers of gynecologic cases were to be diagnosed: 1. 45,000 cases of carcinoma in situ of the cervix. 2. 14,000 new cases of invasive carcinoma of the cervix. 3. 36,000 new cases of cancers of the corpus-endometrium. 4. 19,000 new cases of carcinoma of the ovary. 5. 4,400 new cases of other and unspecified genital tract. This represents a total of 73,400 cases of invasive gynecologic cancer and 45,000 cases of in-situ carcinoma of the uterine cervix to be seen in 1986, constituting 15{\%} of all cancers and about 9{\%} of all cancers in women. The desired principle of multidiscipline management for gynecologic cancer is now well established. The best results in treatment may be anticipated when the treatment is carried out by physicians well acquainted with pelvic anatomy, the characteristics of the malignant disease, and the modalities to be used, whether surgery, radiation therapy, or chemotherapy. However, radiation therapy remains the most generally applicable method for control of gynecologic cancer. At present, these malignant tumors are being discovered earlier and emphasis on the importance of surgery in the management of the early disease is increasing. As an example, more than 75{\%} of all invasive cancers of the cervix are now Stage I and II. In dealing with the wide variety of gynecologic cancers, extreme care must be exercised to choose the appropriate treatment program for each problem since undertreatment or overtreatment are equally undesirable. Each treatment technique may have severe or fatal sequelae if inappropriately used.",
author = "Brady, {L. W.} and Arnold Markoe and T. DeEulis and Lewis, {G. C.}",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "14",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Gynecology

T2 - Combined radiotherapy and chemotherapy in gynecologic oncology

AU - Brady, L. W.

AU - Markoe, Arnold

AU - DeEulis, T.

AU - Lewis, G. C.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - In 1986, 930,000 new cases of invasive cancer were anticipated to be diagnosed in the United States. During the same time period, the following numbers of gynecologic cases were to be diagnosed: 1. 45,000 cases of carcinoma in situ of the cervix. 2. 14,000 new cases of invasive carcinoma of the cervix. 3. 36,000 new cases of cancers of the corpus-endometrium. 4. 19,000 new cases of carcinoma of the ovary. 5. 4,400 new cases of other and unspecified genital tract. This represents a total of 73,400 cases of invasive gynecologic cancer and 45,000 cases of in-situ carcinoma of the uterine cervix to be seen in 1986, constituting 15% of all cancers and about 9% of all cancers in women. The desired principle of multidiscipline management for gynecologic cancer is now well established. The best results in treatment may be anticipated when the treatment is carried out by physicians well acquainted with pelvic anatomy, the characteristics of the malignant disease, and the modalities to be used, whether surgery, radiation therapy, or chemotherapy. However, radiation therapy remains the most generally applicable method for control of gynecologic cancer. At present, these malignant tumors are being discovered earlier and emphasis on the importance of surgery in the management of the early disease is increasing. As an example, more than 75% of all invasive cancers of the cervix are now Stage I and II. In dealing with the wide variety of gynecologic cancers, extreme care must be exercised to choose the appropriate treatment program for each problem since undertreatment or overtreatment are equally undesirable. Each treatment technique may have severe or fatal sequelae if inappropriately used.

AB - In 1986, 930,000 new cases of invasive cancer were anticipated to be diagnosed in the United States. During the same time period, the following numbers of gynecologic cases were to be diagnosed: 1. 45,000 cases of carcinoma in situ of the cervix. 2. 14,000 new cases of invasive carcinoma of the cervix. 3. 36,000 new cases of cancers of the corpus-endometrium. 4. 19,000 new cases of carcinoma of the ovary. 5. 4,400 new cases of other and unspecified genital tract. This represents a total of 73,400 cases of invasive gynecologic cancer and 45,000 cases of in-situ carcinoma of the uterine cervix to be seen in 1986, constituting 15% of all cancers and about 9% of all cancers in women. The desired principle of multidiscipline management for gynecologic cancer is now well established. The best results in treatment may be anticipated when the treatment is carried out by physicians well acquainted with pelvic anatomy, the characteristics of the malignant disease, and the modalities to be used, whether surgery, radiation therapy, or chemotherapy. However, radiation therapy remains the most generally applicable method for control of gynecologic cancer. At present, these malignant tumors are being discovered earlier and emphasis on the importance of surgery in the management of the early disease is increasing. As an example, more than 75% of all invasive cancers of the cervix are now Stage I and II. In dealing with the wide variety of gynecologic cancers, extreme care must be exercised to choose the appropriate treatment program for each problem since undertreatment or overtreatment are equally undesirable. Each treatment technique may have severe or fatal sequelae if inappropriately used.

UR - http://www.scopus.com/inward/record.url?scp=0023684449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023684449&partnerID=8YFLogxK

M3 - Article

VL - 14

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - SUPPL. 1

ER -